Targeting VEGF in cancer therapy

被引：26

作者：

不详

机构：

来源：

CURRENT PROBLEMS IN CANCER | 2006年 / 30卷 / 01期

关键词：

D O I：

10.1016/j.currproblcancer.2005.11.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：7 / 32

页数：26

共 99 条

[1] Kinase inhibition with BAY 43-9006 n renal cell carcinoma [J].

Ahmad, T ;

Eisen, T .

CLINICAL CANCER RESEARCH, 2004, 10 (18) :6388S-6392S

[2] CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer [J].

André, T ;

Louvet, C ;

Maindrault-Goebel, F ;

Couteau, C ;

Mabro, M ;

Lotz, JP ;

Gilles-Amar, V ;

Krulik, M ;

Carola, E ;

Izrael, V ;

de Gramont, A .

EUROPEAN JOURNAL OF CANCER, 1999, 35 (09) :1343-1347

[3]

BASELGA J, 2005, P AN M AM SOC CLIN, pA3028

[4]

Bukowski R M, 2001, Semin Urol Oncol, V19, P148

[5]

Burstein HJ, 2002, BREAST CANCER RES TR, V76, pS115

[6]

CHEN H, 2004, P AN M AM SOC CLIN, pA3515

[7] A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer [J].

Cobleigh, MA ;

Langmuir, VK ;

Sledge, GW ;

Miller, KD ;

Haney, L ;

Novotny, WF ;

Reimann, JD ;

Vassel, A .

SEMINARS IN ONCOLOGY, 2003, 30 (05) :117-124

[8] Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein [J].

Cockman, ME ;

Masson, N ;

Mole, DR ;

Jaakkola, P ;

Chang, GW ;

Clifford, SC ;

Maher, ER ;

Pugh, CW ;

Ratcliffe, PJ ;

Maxwell, PH .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25733-25741

[9]

COHEN R, 2004, P AN M AM SOC CLIN, pA3014

[10]

CROSSEY PA, 1994, HUM GENET, V93, P53

← 1 2 3 4 5 6 7 8 9 10 →